---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-25-000757"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:05:18.944541+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Immunic prices $65M underwritten offering of pre-funded warrants and Series A/B warrants

## Summary
- Offering of 86.7M pre-funded warrants plus Series A & B warrants at $0.7499 per unit; proceeds ~$65M.
- Series A warrants ($0.75 exercise) expire Dec 31, 2025; Series B warrants ($0.75) exercisable from Oct 2025 or upon VWAP ≥$1.25.
- Potential additional $130M gross proceeds if Series A and B warrants fully exercised for cash.
- Leerink Partners sole bookrunner; B. Riley Securities and Brookline Capital co-managers; close expected June 3, 2025.
- Proceeds to fund clinical trials and operations.

## SEC filing metadata
- accession: 0001193805-25-000757
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380525000757/0001193805-25-000757-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380525000757/e664551_8k-immunicpricing.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-25-000757
- JSON: https://secwatch.observer/filing/0001193805-25-000757.json
- Plain text: https://secwatch.observer/filing/0001193805-25-000757.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.